Literature DB >> 24117692

Randomised controlled trial: sequential vs. standard triple therapy for Helicobacter pylori infection in Chinese children-a multicentre, open-labelled study.

J Huang1, L Zhou, L Geng, M Yang, X-W Xu, Z-L Ding, M Mao, Z-L Wang, Z-L Li, D-Y Li, S-T Gong.   

Abstract

BACKGROUND: Studies have showed that 10-day sequential treatment regimen achieved higher Helicobacter pylori eradication rate than standard triple therapies. AIM: To compare a 10-day sequential therapy and standard triple therapy in Chinese children with H. pylori infection.
METHODS: A prospective, multicentre, open-label, randomised controlled trial was conducted in four tertiary medical centres in China. Children with H. pylori gastritis were randomly assigned to a 10-day sequential therapy consisting of omeprazole and amoxicillin for 5 days followed by omeprazole, clarithromycin and metronidazole for the remaining 5 days, or 7-day or 10-day standard triple therapy comprising of omeprazole, amoxicillin and clarithromycin. H. pylori eradication was assessed by H. pylori stool antigen test.
RESULTS: A total of 360 patients were included. The eradication rate achieved with the 10-day sequential therapy was significantly higher than either the 7-day or 10-day standard triple treatment, either by the intention-to-treat analysis (81.4% vs. 61.9% or 67.7%, P < 0.05) or per-protocol analysis (89.7% vs. 70.8% or 77.8%, P < 0.05).
CONCLUSIONS: The 10-day sequential regimen was significantly more effective than standard 7-day or 10-day triple regimens in eradicating H. pylori infection in Chinese children.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24117692     DOI: 10.1111/apt.12516

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  6 in total

Review 1.  Standard triple therapy for Helicobacter pylori infection in China: a meta-analysis.

Authors:  Ben Wang; Zhi-Fa Lv; You-Hua Wang; Hui Wang; Xiao-Qun Liu; Yong Xie; Xiao-Jiang Zhou
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 2.  Treatment of Pediatric Helicobacter pylori Infection.

Authors:  Hung-Hsiang Lai; Ming-Wei Lai
Journal:  Antibiotics (Basel)       Date:  2022-06-01

3.  New Diagnostic Strategies for Detection of Helicobacter pylori Infection in Pediatric Patients.

Authors:  Benjamin D Gold; Mark A Gilger; Steven J Czinn
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-12

4.  Probiotics improve the efficacy of standard triple therapy in the eradication of Helicobacter pylori: a meta-analysis.

Authors:  Christine S M Lau; Amanda Ward; Ronald S Chamberlain
Journal:  Infect Drug Resist       Date:  2016-12-07       Impact factor: 4.003

5.  Long-term effect of the eradication of Helicobacter pylori on the hemoglobin A1c in type 2 diabetes or prediabetes patients.

Authors:  Won Seok Kim; Yonghoon Choi; Nayoung Kim; Seon Hee Lim; Gitark Noh; Ki Wook Kim; Jaehyung Park; Hyeongho Jo; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Dong Ho Lee
Journal:  Korean J Intern Med       Date:  2022-01-07       Impact factor: 3.165

6.  The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood.

Authors:  Seiichi Kato; Toshiaki Shimizu; Shigeru Toyoda; Benjamin D Gold; Shinobu Ida; Takashi Ishige; Shigeru Fujimura; Shigeru Kamiya; Mutsuko Konno; Kentaro Kuwabara; Kosuke Ushijima; Norikazu Yoshimura; Yoshiko Nakayama
Journal:  Pediatr Int       Date:  2020-12       Impact factor: 1.524

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.